Sensus Healthcare, Inc. Overview
Pro stress-test →Sensus Healthcare specializes in non-invasive treatments for skin conditions through Superficial Radiation Therapy (SRT) technology. The company manufactures superficial radiotherapy systems used to treat both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and keloids.
Strategic Profile
Pro stress-test →The company recently received exclusive and dedicated CPT codes from CMS for SRT technology, ensuring clear reimbursement for non-melanoma skin cancer treatments. Sensus is positioned for high-margin revenue and market share gains in expanding oncology settings driven by rising skin cancer incidence.
Competitive Landscape
Pro stress-test →Competition from alternative therapies and cost constraints could suppress equipment sales and slow adoption. Sensus competes with dermatology laser manufacturers and advanced radiation therapy providers, with competitive advantages rooted in non-invasive positioning and emerging reimbursement clarity.
Industry Context
Sensus Healthcare, Inc. operates in Medical Devices - Dermatology & Radiation Oncology.
Key facts
Founded: 2010 · Headquarters: Boca Raton, Florida · Revenue: $27.5M · Market cap: $65M